NightHawk Biosciences, Inc.
Save
10.78M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and ComPACT, which delivers antigen driven T-cell activation and specific co-stimulation in a single product.

Similar securities

Based on sector and market capitalization

Report issue